We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Bioseek | LSE:ATD | London | Ordinary Share | GB0009231639 | ORD 5P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.50 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Jul 2019 to Jul 2024
TIDMATD
RNS Number : 2965N
Asterand PLC
31 August 2011
For Immediate Release 31 August 2011
Asterand plc
("Asterand" or the "Company")
Board Changes
The Company wishes to announce that John Stchur has decided to step down as Chief Financial Officer, with immediate effect.
John has been responsible for leading the Company financially throughout its growth cycle, most recently negotiating the successful acquisition of BioSeek.
The Company has retained Mr. Alan Fishman as the Interim CFO. Mr. Fishman brings over 30 years of financial experience to the Company.
Jack Davis, the Chairman and Interim CEO, said: "John has been a steady hand and positive influence at the Company for 9 years and we wish him well in the future."
Contacts:
Asterand plc Jack Davis, Chairman and Interim Chief Tel: + 44 (0) 1763 211 600 / + Executive Officer 1 (313) 263-0960 John Stchur, Chief Financial Officer As above Buchanan Communications Lisa Baderoon / Mark Court / Isabel Tel: +44 (0) 20 7466 5000 Podda Daniel Stewart & Company plc Antony Legge Tel: +44 (0) 20 7776 6550 Martin Lampshire
About Asterand
Asterand plc is a leading supplier of high quality human tissue and tissue-based services. Our comprehensive approach to human tissue and research services offers pharmaceutical, biotech and diagnostic companies the unique opportunity to have one company meet all of their human biomaterial needs along the continuum of drug discovery and development. Our mission is to accelerate target discovery and compound validation and enable pharmaceutical and biotechnology companies to take safer and more effective drugs into the market. For more information about Asterand, go to www.asterand.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOAZFLBXFVFXBBQ
1 Year Bioseek Chart |
1 Month Bioseek Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
